Skip to main content

Eversept Partners, LP

SEC CIK
0001697013
Latest filing
Aug 14, 2026

MLTX holding history

MoonLake Immunotherapeutics in every 13F filed by Eversept Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings

Shares (Q3 2024)
0
Sold out in Q3 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2024
Holdings of MLTX by Eversept Partners, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20240$00.0%−71,596−100.0%Sold outHolders
Q2 202471,596$3.15M0.2%+71,596NewHolders